Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, gene-editing approaches, including CRISPR/Cas9 technology allow for the ability to create isogenic controls from these patient-derived cells and also introduce disease-causing mutations in unaffected cells, leading to the generation of new disease models (Cong et al., 2013, Muffat et al., 2016, Poon et al., 2017).”
From Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids (2020) · cites this paper as Poon et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727 · cited 1×
“Scaffold-based methods can be further subdivided into polymeric hard scaffolds [78], biologic scaffolds [79] and micropatterned surface [80].”
MethodCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“In addition to oxidative stress, Ab released into the extracellular space binds and activates resident innate immune cells such as microglia, which subsequently release inflammatory mediators that contribute to chronic neuroinflammation, and is closely associated with AD progression/severity [24,25].”
BackgroundBrain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Qian, X., Nguyen, H. N., Song, M. M., Hadiono, C., Ogden, S. C., Hammack, C., Yao, B., Hamersky, G. R., Jacob, F., Zhong, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.032 · Cited by 2,127 · cited 1×
“for using forebrain organoids to model zika virus exposure and zika-associated microcephaly [94].”
MethodRogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture
Paşca, A. M., Sloan, S. A., Clarke, L. E., Tian, Y., Makinson, C. D., Huber, N., Kim, C. H., Park, J.-Y., O'Rourke, N. A., Nguyen, K. D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3415 · Cited by 1,609 · cited 1×
“who showed the possibility of obtaining functional cortical neurons with properties of deep and superficial layers using 3D culture system [93] and Qian et al.”
MethodMarchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · cited 4×
“The b-secretase is localized to endosomes and the authors also identified an abnormal presence of large endosomes (RAB5+) in their patientderived neurons, which is consistent with observations in postmortem brains of AD patients [2,22].”
BackgroundResultInfluential
Research works printed but not linked: 71
- Duan, 2014, Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death, Mol Neurodegener, 9, 3, 10.1186/1750-1326-9-3 · DOI · Paper page
- Sproul, 2014, Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors, PLoS One, 9, e84547, 10.1371/journal.pone.0084547 · DOI · Paper page
- Apostolova, 2016, Alzheimer disease, Continuum (Minneap Minn), 22, 419, 10.1212/CON.0000000000000307 · DOI · Paper page
- Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun, 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- Kosik, 1986, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc Natl Acad Sci U S A, 83, 4044, 10.1073/pnas.83.11.4044 · DOI · Paper page
- Alzheimer, 1911, Über eigenartige Krankheitsfalle des späteren Alters, Zbl ges Neurol Psych, 4, 356, 10.1007/BF02866241 · DOI · Paper page
- Goate, 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349, 704, 10.1038/349704a0 · DOI · Paper page
- Schellenberg, 1993, Chromosome 14 and late-onset familial Alzheimer disease (FAD), Am J Hum Genet, 53, 619
- St George-Hyslop, 1987, The genetic defect causing familial Alzheimer's disease maps on chromosome 21, Science, 235, 885, 10.1126/science.2880399 · DOI · Paper page
- Jiang, 2013, Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors, Curr Alzheimer Res, 10, 852, 10.2174/15672050113109990155 · DOI · Paper page
- Yegambaram, 2015, Role of environmental contaminants in the etiology of Alzheimer's disease: a review, Curr Alzheimer Res, 12, 116, 10.2174/1567205012666150204121719 · DOI · Paper page
- Cataldo, 2001, Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders, Ann Neurol, 50, 661, 10.1002/ana.1254 · DOI · Paper page
- Mufson, 2002, Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease, J Comp Neurol, 443, 136, 10.1002/cne.10122 · DOI · Paper page
- Heneka, 2015, Neuroinflammation in Alzheimer's disease, Lancet Neurol, 14, 388, 10.1016/S1474-4422(15)70016-5 · DOI · Paper page
- Balez, 2016, Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease, Sci Rep, 6, 31450, 10.1038/srep31450 · DOI · Paper page
- Lancaster, 2014, Generation of cerebral organoids from human pluripotent stem cells, Nat Protoc, 9, 2329, 10.1038/nprot.2014.158 · DOI · Paper page
- Asim, 2015, Down syndrome: an insight of the disease, J Biomed Sci, 22, 41, 10.1186/s12929-015-0138-y · DOI · Paper page
- Wiseman, 2009, Down syndrome–recent progress and future prospects, Hum Mol Genet, 18, R75, 10.1093/hmg/ddp010 · DOI · Paper page
- Weick, 2016, Gene expression studies on human trisomy 21 iPSCs and neurons: towards mechanisms underlying down's syndrome and early Azheimer's disease-like pathologies, Methods Mol Biol, 1303, 247, 10.1007/978-1-4939-2627-5_15 · DOI
- Rumble, 1989, Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease, N Engl J Med, 320, 1446, 10.1056/NEJM198906013202203 · DOI · Paper page
- Shi, 2008, Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome, J Biol Chem, 283, 28660, 10.1074/jbc.M802645200 · DOI · Paper page
- Chang, 2015, N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons, Sci Rep, 5, 8744, 10.1038/srep08744 · DOI
- Briggs, 2013, Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology, Stem Cells, 31, 467, 10.1002/stem.1297 · DOI · Paper page
- Weick, 2013, Deficits in human trisomy 21 iPSCs and neurons, Proc Natl Acad Sci U S A, 110, 9962, 10.1073/pnas.1216575110 · DOI · Paper page
- Bang, 2015, Frontotemporal dementia, Lancet, 386, 1672, 10.1016/S0140-6736(15)00461-4 · DOI · Paper page
- DeJesus-Hernandez, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011 · DOI · Paper page
- Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010 · DOI · Paper page
- Rademakers, 2004, The role of tau (MAPT) in frontotemporal dementia and related tauopathies, Hum Mutat, 24, 277, 10.1002/humu.20086 · DOI · Paper page
- Capell, 2014, Progranulin transcripts with short and long 5' untranslated regions (UTRs) are differentially expressed via posttranscriptional and translational repression, J Biol Chem, 289, 25879, 10.1074/jbc.M114.560128 · DOI
- Hu, 2009, TDP-43 and frontotemporal dementia, Curr Neurol Neurosci Rep, 9, 353, 10.1007/s11910-009-0052-3 · DOI
- Bersano, 2009, Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation, Neurobiol Aging, 30, 752, 10.1016/j.neurobiolaging.2007.08.009 · DOI
- Urwin, 2009, The role of CHMP2B in frontotemporal dementia, Biochem Soc Trans, 37, 208, 10.1042/BST0370208 · DOI
- Donnelly, 2013, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention, Neuron, 80, 415, 10.1016/j.neuron.2013.10.015 · DOI · Paper page
- Biswas, 2016, MMP-9 and MMP-2 contribute to neuronal cell death in iPSC models of frontotemporal dementia with MAPT mutations, Stem Cell Rep, 7, 316, 10.1016/j.stemcr.2016.08.006 · DOI · Paper page
- Lee, 2014, Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency, Hum Mol Genet, 23, 1467, 10.1093/hmg/ddt534 · DOI · Paper page
- Raitano, 2015, Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia, Stem Cell Rep, 4, 16, 10.1016/j.stemcr.2014.12.001 · DOI
- Almeida, 2012, Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects, Cell Rep, 2, 789, 10.1016/j.celrep.2012.09.007 · DOI · Paper page
- Zhang, 2017, Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B, Stem Cell Rep, 8, 648, 10.1016/j.stemcr.2017.01.012 · DOI
- Shi, 2012, Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks, Nat Protoc, 7, 1836, 10.1038/nprot.2012.116 · DOI · Paper page
- Krishnamurthy, 2004, Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model, J Biol Chem, 279, 7893, 10.1074/jbc.M311203200 · DOI · Paper page
- Rasmussen, 2016, Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT), Stem Cell Res, 16, 70, 10.1016/j.scr.2015.12.008 · DOI
- Rasmussen, 2016, Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT), Stem Cell Res, 16, 75, 10.1016/j.scr.2015.12.006 · DOI
- Nimsanor, 2016, Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAPT) gene, Stem Cell Res, 17, 556, 10.1016/j.scr.2016.09.021 · doi:10.1016/j.scr.2016.09.021
- Nimsanor, 2016, Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene, Stem Cell Res, 17, 576, 10.1016/j.scr.2016.09.020 · doi:10.1016/j.scr.2016.09.020
- Nimsanor, 2016, Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene, Stem Cell Res, 17, 600, 10.1016/j.scr.2016.09.024 · DOI
- Koch, 2011, Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease, Nature, 480, 543, 10.1038/nature10671 · DOI · Paper page
- Hansen, 2016, Induced pluripotent stem cell – derived neurons for the study of spinocerebellar ataxia type 3, Stem Cell Res, 17, 306, 10.1016/j.scr.2016.07.004 · DOI
- Marthaler, 2016, Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196, Stem Cell Res, 16, 199, 10.1016/j.scr.2015.12.049 · doi:10.1016/j.scr.2015.12.049
- Marthaler, 2016, Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H266, Stem Cell Res, 16, 166, 10.1016/j.scr.2015.12.029 · doi:10.1016/j.scr.2015.12.029
- Marthaler, 2016, Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H271, Stem Cell Res, 16, 159, 10.1016/j.scr.2015.12.027 · doi:10.1016/j.scr.2015.12.027
- Mertens, 2016, Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience, Nat Rev Neurosci, 17, 424, 10.1038/nrn.2016.46 · DOI · Paper page
- Taroni, 2004, Pathways to motor incoordination: the inherited ataxias, Nat Rev Neurosci, 5, 641, 10.1038/nrn1474 · DOI · Paper page
- Su, 2006, Generation of cerebellar neuron precursors from embryonic stem cells, Dev Biol, 290, 287, 10.1016/j.ydbio.2005.11.010 · DOI
- Muguruma, 2010, Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells, Nat Neurosci, 13, 1171, 10.1038/nn.2638 · DOI · Paper page
- Morino, 2015, A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia, Mol Brain, 8, 89, 10.1186/s13041-015-0180-4 · DOI
- Wang, 2015, Differentiation of human induced pluripotent stem cells to mature functional Purkinje neurons, Sci Rep, 5, 9232, 10.1038/srep09232 · DOI
- Chaudhari, 2016, Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review, Int J Mol Sci, 17, 10.3390/ijms17121974 · DOI · Paper page
- Hu, 2016, Micropatterned hydrogel surface with high-aspect-ratio features for cell guidance and tissue growth, ACS Appl Mater Interfaces, 8, 21939, 10.1021/acsami.5b12268 · DOI
- Raghavan, 2015, Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays, Gynecol Oncol, 138, 181, 10.1016/j.ygyno.2015.04.014 · DOI
- Ivanov, 2014, Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres, PLoS One, 9, e103817, 10.1371/journal.pone.0103817 · DOI · Paper page
- Jang, 2015, On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro, Biomicrofluidics, 9, 034113, 10.1063/1.4922863 · DOI
- Cui, 2017, Advances in multicellular spheroids formation, J R Soc Interface, 14, 10.1098/rsif.2016.0877 · DOI · Paper page
- Schizas, 2014, Hyaluronic acid-based hydrogel enhances neuronal survival in spinal cord slice cultures from postnatal mice, J Biomater Appl, 28, 825, 10.1177/0885328213483636 · DOI
- Park, 2010, Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor, J Biomed Mater Res A, 93, 1091, 10.1002/jbm.a.32519 · DOI · Paper page
- Kunze, 2011, Micropatterning neural cell sultures in 3D with a multilayered scaffold, Biomaterials, 32, 2088, 10.1016/j.biomaterials.2010.11.047 · DOI
- Marton, 2016, Neural differentiation in the third dimension: generating a human midbrain, Cell Stem Cell, 19, 145, 10.1016/j.stem.2016.07.017 · DOI
- Preynat-Seauve, 2009, Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture, Stem Cells, 27, 509, 10.1002/stem.20080600 · doi:10.1002/stem.20080600
- Tieng, 2014, Engineering of midbrain organoids containing long-lived dopaminergic neurons, Stem Cells Dev, 23, 1535, 10.1089/scd.2013.0442 · DOI
- Lancaster, 2013, Cerebral organoids model human brain development and microcephaly, Nature, 501, 373, 10.1038/nature12517 · DOI · Paper page
- Kelava, 2016, Dishing out mini-brains: current progress and future prospects in brain organoid research, Dev Biol, 420, 199, 10.1016/j.ydbio.2016.06.037 · DOI · Paper page
- Zhang, 2016, Layered hydrogels accelerate iPSC-derived neuronal maturation and reveal migration defects caused by MeCP2 dysfunction, Proc Natl Acad Sci U S A, 113, 3185, 10.1073/pnas.1521255113 · DOI · Paper page
Cited by
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Hemonnot, A.-L., Hua, J., Ulmann, L., & Hirbec, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00233 · Cited by 298
VanderWall, K. B., Huang, K.-C., Pan, Y., Lavekar, S. S., Fligor, C. M., Allsop, A. R., Lentsch, K. A., Dang, P., Zhang, C., Tseng, H. C., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.009 · Cited by 108
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Silva-Pedrosa, R., Salgado, A. J., & Ferreira, P. E. (2023) · Cells · doi:10.3390/cells12060930 · Cited by 84
Garcia, G., Pinto, S., Cunha, M., Fernandes, A., Koistinaho, J., & Brites, D. (2021) · Cells · doi:10.3390/cells10092424 · Cited by 39
“Alternatively, iPSCs started to be generated from patient fibroblasts, and the use of iPSCs-differentiated neurons allowed for studies on sporadic and familiar cases of AD that better mimic the pathological condition [69].”
Background
Metadata
- Authors
- Poon, A., Zhang, Y., Chandrasekaran, A., Phanthong, P., Schmid, B., Nielsen, T. T., & Freude, K. K.
- Venue
- New Biotechnology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 39
- Pages
- 190-198
- ISSN
- 1871-6784
- Cited by
- 46
- References
- 29
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- The China Scholarship Council
- Mahidol University research fund
- The European Union 7th Framework Program
- Innovation Fund Denmark
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges. https://app.cochat.ai/papers/10.1016/j.nbt.2017.05.009
- The paper
- Poon, A., Zhang, Y., Chandrasekaran, A., Phanthong, P., Schmid, B., Nielsen, T. T., & Freude, K. K. (2017). Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges. New Biotechnology. https://doi.org/10.1016/j.nbt.2017.05.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.